Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.670 HKD | -0.81% |
|
+0.55% | -1.61% |
Mar. 05 | Lee & Man Chemical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
2024 | Lee & Man Chemical Company Limited(SEHK:746) dropped from S&P Global BMI Index | CI |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.37 | 13.68 | 11.81 | 4.19 | 4.84 | |||||
Return on Total Capital | 6.1 | 15.64 | 13.36 | 4.6 | 5.27 | |||||
Return On Equity % | 12.12 | 25.71 | 20.64 | 7.01 | 8.22 | |||||
Return on Common Equity | 12.12 | 25.71 | 20.64 | 7.01 | 8.22 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 36.5 | 45.1 | 36.19 | 26.22 | 29.46 | |||||
SG&A Margin | 13.7 | 10.27 | 9.06 | 11.56 | 12.09 | |||||
EBITDA Margin % | 19.36 | 31.38 | 24.89 | 13.13 | 15.78 | |||||
EBITA Margin % | 17.93 | 30.44 | 23.71 | 11.75 | 14 | |||||
EBIT Margin % | 17.85 | 30.38 | 23.66 | 11.68 | 13.93 | |||||
Income From Continuing Operations Margin % | 16.22 | 24.84 | 19.72 | 9.89 | 12.21 | |||||
Net Income Margin % | 16.22 | 24.84 | 19.72 | 9.89 | 12.21 | |||||
Net Avail. For Common Margin % | 16.22 | 24.84 | 19.72 | 9.89 | 12.21 | |||||
Normalized Net Income Margin | 12.66 | 19.47 | 14.87 | 7.83 | 9.45 | |||||
Levered Free Cash Flow Margin | -3.14 | 2.61 | 9.47 | -7.05 | -3.66 | |||||
Unlevered Free Cash Flow Margin | -2.01 | 3.18 | 9.88 | -6.44 | -3.31 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.48 | 0.72 | 0.8 | 0.57 | 0.56 | |||||
Fixed Assets Turnover | 0.7 | 1.05 | 1.16 | 0.83 | 0.77 | |||||
Receivables Turnover (Average Receivables) | 11.4 | 16.5 | 19.63 | 15.45 | 11.83 | |||||
Inventory Turnover (Average Inventory) | 3.73 | 4.49 | 4.66 | 3.66 | 4.01 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.52 | 1.6 | 1.51 | 1.29 | 1.21 | |||||
Quick Ratio | 0.58 | 0.56 | 0.62 | 0.51 | 0.64 | |||||
Operating Cash Flow to Current Liabilities | 0.75 | 1.11 | 1.41 | 0.65 | 0.92 | |||||
Days Sales Outstanding (Average Receivables) | 32.09 | 22.13 | 18.59 | 23.62 | 30.94 | |||||
Days Outstanding Inventory (Average Inventory) | 98.08 | 81.21 | 78.32 | 99.66 | 91.19 | |||||
Average Days Payable Outstanding | 44.06 | 25.56 | 18.72 | 22.54 | 23.53 | |||||
Cash Conversion Cycle (Average Days) | 86.11 | 77.78 | 78.2 | 100.75 | 98.61 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 34.63 | 18.61 | 13.25 | 11.71 | 11 | |||||
Total Debt / Total Capital | 25.72 | 15.69 | 11.7 | 10.48 | 9.91 | |||||
LT Debt/Equity | 24.25 | 10.81 | 3.92 | 0.08 | 1.06 | |||||
Long-Term Debt / Total Capital | 18.01 | 9.11 | 3.46 | 0.07 | 0.95 | |||||
Total Liabilities / Total Assets | 34.45 | 26.82 | 20.4 | 17.49 | 17.52 | |||||
EBIT / Interest Expense | 9.91 | 33.08 | 35.91 | 12.05 | 25.14 | |||||
EBITDA / Interest Expense | 10.82 | 34.28 | 37.9 | 13.69 | 28.75 | |||||
(EBITDA - Capex) / Interest Expense | 2.25 | 20.15 | 22.09 | -0.27 | -6.17 | |||||
Total Debt / EBITDA | 2.55 | 0.64 | 0.51 | 1.26 | 1.04 | |||||
Net Debt / EBITDA | 1.91 | 0.44 | 0.22 | 0.77 | 0.58 | |||||
Total Debt / (EBITDA - Capex) | 12.22 | 1.08 | 0.87 | -65.08 | -4.83 | |||||
Net Debt / (EBITDA - Capex) | 9.15 | 0.74 | 0.38 | -39.81 | -2.68 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -10.84 | 67.31 | 13.13 | -30.96 | -2.46 | |||||
Gross Profit, 1 Yr. Growth % | -18.37 | 106.7 | -9.21 | -49.98 | 9.59 | |||||
EBITDA, 1 Yr. Growth % | -30.38 | 171.26 | -10.28 | -63.57 | 17.24 | |||||
EBITA, 1 Yr. Growth % | -32.18 | 183.97 | -11.87 | -65.79 | 16.21 | |||||
EBIT, 1 Yr. Growth % | -32.49 | 184.8 | -11.89 | -65.91 | 16.32 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -28.28 | 156.25 | -10.19 | -65.36 | 20.37 | |||||
Net Income, 1 Yr. Growth % | -28.28 | 156.25 | -10.19 | -65.36 | 20.37 | |||||
Normalized Net Income, 1 Yr. Growth % | -26.25 | 157.36 | -13.62 | -63.64 | 17.74 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -28.28 | 147.78 | -10.93 | -64.43 | 22.3 | |||||
Accounts Receivable, 1 Yr. Growth % | -11.03 | 45.65 | -39.65 | 33.05 | 23.18 | |||||
Inventory, 1 Yr. Growth % | -8.34 | 51.15 | 10.71 | -6.68 | -23.71 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 11.01 | 10.72 | -6.02 | 0.44 | 8.67 | |||||
Total Assets, 1 Yr. Growth % | 11.22 | 12.38 | -7.11 | -0.67 | 2.38 | |||||
Tangible Book Value, 1 Yr. Growth % | 15.71 | 26.04 | 1.28 | 3.07 | 2.46 | |||||
Common Equity, 1 Yr. Growth % | 15.4 | 25.46 | 1.04 | 2.96 | 2.35 | |||||
Cash From Operations, 1 Yr. Growth % | -12.93 | 68.24 | 8.13 | -52.72 | 39.61 | |||||
Capital Expenditures, 1 Yr. Growth % | -26.06 | 40.6 | -9.17 | -10.31 | 39.54 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -59.98 | -239.1 | 310.7 | -151.38 | -49.35 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -67.93 | -364.76 | 251.26 | -145 | -49.83 | |||||
Dividend Per Share, 1 Yr. Growth % | -27.27 | 141.67 | -5.17 | -65.45 | 52.63 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -10.58 | 22.13 | 37.58 | -11.62 | -17.94 | |||||
Gross Profit, 2 Yr. CAGR % | -21.05 | 29.9 | 36.99 | -32.61 | -25.96 | |||||
EBITDA, 2 Yr. CAGR % | -30.43 | 37.42 | 56 | -42.83 | -34.65 | |||||
EBITA, 2 Yr. CAGR % | -32.04 | 38.78 | 58.2 | -45.09 | -36.94 | |||||
EBIT, 2 Yr. CAGR % | -32.1 | 38.66 | 58.41 | -45.19 | -37.03 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -24.09 | 35.57 | 51.71 | -44.23 | -35.43 | |||||
Net Income, 2 Yr. CAGR % | -24.11 | 35.57 | 51.71 | -44.23 | -35.43 | |||||
Normalized Net Income, 2 Yr. CAGR % | -26.03 | 37.77 | 49.1 | -43.96 | -34.57 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -23.57 | 33.29 | 48.56 | -43.72 | -34.05 | |||||
Accounts Receivable, 2 Yr. CAGR % | 5.85 | 13.84 | -6.25 | -10.39 | 28.02 | |||||
Inventory, 2 Yr. CAGR % | -7.21 | 17.7 | 29.36 | 1.64 | -15.63 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 10.42 | 10.86 | 2.01 | -2.84 | 4.47 | |||||
Total Assets, 2 Yr. CAGR % | 5.81 | 11.8 | 2.17 | -3.94 | 0.84 | |||||
Tangible Book Value, 2 Yr. CAGR % | 13.42 | 20.77 | 12.98 | 2.17 | 2.77 | |||||
Common Equity, 2 Yr. CAGR % | 13.02 | 20.33 | 12.59 | 2 | 2.65 | |||||
Cash From Operations, 2 Yr. CAGR % | -19.64 | 21.03 | 34.87 | -28.5 | -18.75 | |||||
Capital Expenditures, 2 Yr. CAGR % | -4.45 | 1.96 | 13.01 | -9.74 | 11.87 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -38.48 | -25.38 | 139.02 | 45.26 | -48.99 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -55.55 | -7.85 | 204.96 | 25.72 | -52.49 | |||||
Dividend Per Share, 2 Yr. CAGR % | -20.53 | 32.57 | 51.38 | -42.76 | -27.39 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.39 | 10.18 | 19.06 | 9.33 | -8.67 | |||||
Gross Profit, 3 Yr. CAGR % | -6.83 | 8.82 | 15.28 | -2.09 | -20.75 | |||||
EBITDA, 3 Yr. CAGR % | -13.69 | 9.5 | 19.21 | -3.93 | -27.37 | |||||
EBITA, 3 Yr. CAGR % | -14.89 | 9.46 | 19.29 | -5.04 | -29.5 | |||||
EBIT, 3 Yr. CAGR % | -14.97 | 9.5 | 19.21 | -5.07 | -29.57 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -10.58 | 13.87 | 18.18 | -7.28 | -27.92 | |||||
Net Income, 3 Yr. CAGR % | -10.58 | 13.86 | 18.18 | -7.28 | -27.92 | |||||
Normalized Net Income, 3 Yr. CAGR % | -12.11 | 12.09 | 17.92 | -6.85 | -28.22 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -10.58 | 13.1 | 16.53 | -7.76 | -27.1 | |||||
Accounts Receivable, 3 Yr. CAGR % | -13.55 | 17.74 | -7.87 | 5.36 | -0.36 | |||||
Inventory, 3 Yr. CAGR % | 5.94 | 9.18 | 15.32 | 16.02 | -7.63 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 7.04 | 10.52 | 4.92 | 1.48 | 0.85 | |||||
Total Assets, 3 Yr. CAGR % | 5 | 7.96 | 5.1 | 1.22 | -1.88 | |||||
Tangible Book Value, 3 Yr. CAGR % | 13.49 | 17.48 | 13.89 | 9.58 | 2.27 | |||||
Common Equity, 3 Yr. CAGR % | 12.97 | 17.02 | 13.52 | 9.28 | 2.11 | |||||
Cash From Operations, 3 Yr. CAGR % | -1 | 2.8 | 16.57 | -4.9 | -10.63 | |||||
Capital Expenditures, 3 Yr. CAGR % | -9.42 | 8.68 | -1.89 | 4.63 | 4.37 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -34.54 | -19.26 | 31.74 | 43.18 | 2.24 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -40.48 | -19.42 | 43.95 | 61.15 | -7.44 | |||||
Dividend Per Share, 3 Yr. CAGR % | -7.17 | 15.14 | 18.56 | -7.49 | -20.63 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 12.69 | 23.38 | 14.56 | 0.88 | 2.59 | |||||
Gross Profit, 5 Yr. CAGR % | 10.88 | 28.87 | 8.7 | -10.16 | -3.43 | |||||
EBITDA, 5 Yr. CAGR % | 7.74 | 33.82 | 9.37 | -15.57 | -6.27 | |||||
EBITA, 5 Yr. CAGR % | 7.62 | 34.94 | 9.06 | -16.93 | -7.56 | |||||
EBIT, 5 Yr. CAGR % | 7.52 | 34.89 | 9.06 | -16.98 | -7.65 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 13.26 | 42.89 | 10.47 | -14.41 | -7.2 | |||||
Net Income, 5 Yr. CAGR % | 13.26 | 42.89 | 10.47 | -14.42 | -7.2 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.99 | 37.25 | 8.58 | -15.05 | -6.83 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 13.26 | 41.93 | 9.54 | -14.45 | -7.2 | |||||
Accounts Receivable, 5 Yr. CAGR % | 14.11 | 11.15 | -10.7 | 5.56 | 5.09 | |||||
Inventory, 5 Yr. CAGR % | 19.53 | 26.88 | 14.75 | 6.1 | 1.77 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 7.32 | 9.37 | 5 | 4.97 | 4.74 | |||||
Total Assets, 5 Yr. CAGR % | 7.96 | 9.9 | 3.86 | 3.03 | 3.38 | |||||
Tangible Book Value, 5 Yr. CAGR % | 13.13 | 18.52 | 13.29 | 11.1 | 9.3 | |||||
Common Equity, 5 Yr. CAGR % | 13.62 | 18.94 | 12.82 | 10.76 | 9.04 | |||||
Cash From Operations, 5 Yr. CAGR % | 6.32 | 22.04 | 12.04 | -11.1 | 0.89 | |||||
Capital Expenditures, 5 Yr. CAGR % | -1.16 | 4.49 | -1.04 | 0.9 | 3.4 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -22.03 | -9.55 | 9.89 | 2.12 | -9.86 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -28.18 | -4.52 | 14.42 | -3.73 | -7.6 | |||||
Dividend Per Share, 5 Yr. CAGR % | 14.87 | 45.16 | 12.89 | -12.94 | -2.55 |
Select your edition
All financial news and data tailored to specific country editions